Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine + Gemcitabine in Advanced NSCLC
NCT05647330Phase 2Unknown
- Sponsor
- Henan Cancer Hospital
- Start
- Dec 2022
- Primary completion
- Oct 2024
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of hydroxychloroquine in non-small cell lung cancer (NSCLC), sponsored by Henan Cancer Hospital. Status: unknown.
02
Drugs
hydroxychloroquine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT05647330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05647330.